Showing results (181-190 of 209) with videos related to
Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology GroupP D Bonomi, D M Finkelstein, J C Ruckdeschel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study GroupN Petrelli, H O Douglass, L Herrera, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2000
Enhancement of platelet recovery after myelosuppressive chemotherapy by recombinant human megakaryocyte growth and development factor in patients with advanced cancerR L Basser, C Underhill, I Davis, et al.Journal of Biological Response Modifiers|August 1, 1988
Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposideR L Krigel, C M Slywotzky, M Lonberg, et al.Blood|November 14, 1997
Enhanced levels and enhanced clonogenic capacity of blood progenitor cells following administration of stem cell factor plus granulocyte colony-stimulating factor to humansC G Begley, R Basser, R Mansfield, et al.Agents and Actions|March 1, 1990
Inhibition of human periodontal prostaglandin E2 synthesis with selected agentsS Offenbacher, B M Odle, M D Green, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group studyH S Hochster, K M Kim, M D Green, et al.Cancer Research|May 1, 1988
Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferonM D Green, J L Speyer, H S Hochster, et al.Cancer Chemotherapy and Pharmacology|January 1, 1988
The disposition of carboplatin in ovarian cancer patientsR C Gaver, N Colombo, M D Green, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumorsS M Talbot, D A Westerman, A P Grigg, et al.Pageof 21